nº93 COMMUNICATIONS ON INDUSTRIAL PROPERTY AND COMPETITION LAW

Available for download.

The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in the Nacional Health System.

Angel García Vidal and Irene Fernández Puyol 

Health Data 29 Playbook as a gvernance framework fot he sharing and researchwith healthcaredata. 

Ricard Martínez Martínez, Gabriel López Serrano, Alejandro Padín Vidal and Iñigo del Hoyo Alegría 

Commercial offers made by companies holding a dominant position in the relevant market. 

Jordi Faus Santasusana and Laura Marquès Mas.

Spanish Draft Royal Decree on medical devices. Preliminary thoughts.

Jorge Robles González

Current legal framework on electronic signature.

Carme Briera Dalmau

Health Data 29 Playbook as a gvernance framework fot he sharing and researchwith healthcaredata. 

Ricard Martínez Martínez, Gabriel López Serrano, Alejandro Padín Vidal and Iñigo del Hoyo Alegría 

The use on the market of a significant  cometititve advantage acquired through the violation of laws as an unfair competition act. A pharmaceutical law example.

Miquel Montañá Mora

Early Neutral Evaluation Report as an alternative dispute resolution on IP conflicts.

Silvia Navares González

New regulation on digital services. Aplicable regime to innovative digital services provided through the Internet.

Jorge Monclús Ruiz and Pedro Méndez de Vigo

Judgement of the Court of Justice os the European Union dated 18 November 2020 (C147/19) review on single equitable remuneration

Juan Cuerva de Cañas

Code of Conduct  on the use of influencers in advertising.

Charo Fernando Magarzo and José Domingo Gómez Castallo

Autocontrol Code of Advertising practice

Jesús Rubí Navarrete

Spanish competition law reform. Transposition of ECN+ Directive: parturiunt montes, nascetur ridiculus mus. 

Rafael Allendesalazar Corcho

Nacional Court has confirmed that free pricing policy does not constitute an anticompetitive dual pricing agreement

Beatriz Cocina Arrieta and Teresa Paz-Ares Rodríguez

Abuse of dominant position consisting on predatory prices. Spanish Competition Authority Astrazeneca inhalers Decision.

Alfonso Gutiérrez Hernández and Alberto Pérez Hernández

Commercial offers made by companies holding a dominant position in the relevant market. 

Jordi Faus Santasusana and Laura Marquès Mas.

Kanavape Case: a posible new dawn for cannabidiol (CBD) in Spain.
Adrián Crespo Velasco

This post is also available in: Spanish